Related Experiment Video
Updated: Feb 17, 2026
An Orthotopic Bladder Cancer Model for Gene Delivery Studies
Published on: December 1, 2013
[Research progress on the effect of glucocorticoid receptor signaling pathways in bladder cancer]
Sheng Feng1, Jijun Chen2, Yichun Zheng3
1Department of Urology, the First Affiliated Hospital, Zhejiang Chinese Medical University, Hangzhou 310006, China; Department of Urology, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, China.
Abstract:
Glucocorticoid receptor (GR) is identified as a member of nuclear receptor family. To exert its biological action, the ligand bound GR is translocated from the cytoplasm into the nucleus by regulating transcriptional signals of related genes. In clinical practice, the effects of glucocorticoid are often mediated by GR signaling pathways. An increasing number of studies have indicated that GR signaling pathways play an essential role in the proliferation, invasion and prognosis of bladder cancer. Meanwhile, the new-generation selective GR activator improves its anti-tumor effects, and at the same time reduces the adverse reactions of hormones, which probably raises the prospect for the treatment of bladder cancer.
Insights
Glucocorticoid receptor (GR) signaling is crucial in bladder cancer progression. Selective GR activators show promise for improved anti-tumor effects and reduced side effects in bladder cancer treatment.
Area of Science:
- Endocrinology
- Oncology
- Molecular Biology
Background:
- The glucocorticoid receptor (GR) is a nuclear receptor that mediates glucocorticoid actions.
- GR signaling pathways regulate gene transcription and are implicated in various biological processes.
- GR plays a significant role in the proliferation, invasion, and prognosis of bladder cancer.
Purpose of the Study:
- To investigate the role of GR signaling pathways in bladder cancer.
- To explore the potential of novel selective GR activators for bladder cancer treatment.
Main Methods:
- Review of existing literature on GR signaling and bladder cancer.
- Analysis of studies investigating the effects of selective GR activators.
Main Results:
- GR signaling pathways are essential for bladder cancer cell proliferation and invasion.
- New-generation selective GR activators demonstrate enhanced anti-tumor efficacy.
- Selective GR activators may reduce the adverse effects associated with traditional hormone therapies.
Conclusions:
- GR signaling is a critical target in bladder cancer.
- Selective GR activators represent a promising therapeutic strategy for bladder cancer, offering improved efficacy and tolerability.
More Related Videos
11:02Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
13:22A Chemical Screening Procedure for Glucocorticoid Signaling with a Zebrafish Larva Luciferase Reporter System
Published on: September 10, 2013
Related Concept Videos
01:15Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
01:19Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
01:20The JAK-STAT Signaling Pathway